178 related articles for article (PubMed ID: 31271204)
1. Reduced PAX2 expression in murine fallopian tube cells enhances estrogen receptor signaling.
Colina JA; Varughese P; Karthikeyan S; Salvi A; Modi DA; Burdette JE
Carcinogenesis; 2020 Jul; 41(5):646-655. PubMed ID: 31271204
[TBL] [Abstract][Full Text] [Related]
2. PAX2 function, regulation and targeting in fallopian tube-derived high-grade serous ovarian cancer.
Modi DA; Tagare RD; Karthikeyan S; Russo A; Dean M; Davis DA; Lantvit DD; Burdette JE
Oncogene; 2017 May; 36(21):3015-3024. PubMed ID: 27991925
[TBL] [Abstract][Full Text] [Related]
3. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
4. The PAX2-null immunophenotype defines multiple lineages with common expression signatures in benign and neoplastic oviductal epithelium.
Ning G; Bijron JG; Yamamoto Y; Wang X; Howitt BE; Herfs M; Yang E; Hong Y; Cornille M; Wu L; Hanamornroongruang S; McKeon FD; Crum CP; Xian W
J Pathol; 2014 Dec; 234(4):478-87. PubMed ID: 25130537
[TBL] [Abstract][Full Text] [Related]
5. Secretory cell outgrowth, PAX2 and serous carcinogenesis in the Fallopian tube.
Chen EY; Mehra K; Mehrad M; Ning G; Miron A; Mutter GL; Monte N; Quade BJ; McKeon FD; Yassin Y; Xian W; Crum CP
J Pathol; 2010 Sep; 222(1):110-6. PubMed ID: 20597068
[TBL] [Abstract][Full Text] [Related]
6. Digital quantification of precursor frequency in the fallopian tube and its significance.
Bijron JG; Ning G; Laury AR; Quick CM; Betensky RA; Monte NM; King E; McKeon FD; Xian W; Crum CP
Mod Pathol; 2012 Dec; 25(12):1654-61. PubMed ID: 22766793
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide transcriptional regulation of estrogen receptor targets in fallopian tube cells and the role of selective estrogen receptor modulators.
Moyle-Heyrman G; Schipma MJ; Dean M; Davis DA; Burdette JE
J Ovarian Res; 2016 Feb; 9():5. PubMed ID: 26879975
[TBL] [Abstract][Full Text] [Related]
8. Fallopian tube correlates of ovarian serous borderline tumors.
Laury AR; Ning G; Quick CM; Bijron J; Parast MM; Betensky RA; Vargas SO; McKeon FD; Xian W; Nucci MR; Crum CP
Am J Surg Pathol; 2011 Dec; 35(12):1759-65. PubMed ID: 22089527
[TBL] [Abstract][Full Text] [Related]
9. Silencing PTEN in the fallopian tube promotes enrichment of cancer stem cell-like function through loss of PAX2.
Russo A; Colina JA; Moy J; Baligod S; Czarnecki AA; Varughese P; Lantvit DD; Dean MJ; Burdette JE
Cell Death Dis; 2021 Apr; 12(4):375. PubMed ID: 33828085
[TBL] [Abstract][Full Text] [Related]
10. Early Loss of Histone H2B Monoubiquitylation Alters Chromatin Accessibility and Activates Key Immune Pathways That Facilitate Progression of Ovarian Cancer.
Hooda J; Novak M; Salomon MP; Matsuba C; Ramos RI; MacDuffie E; Song M; Hirsch MS; Lester J; Parkash V; Karlan BY; Oren M; Hoon DS; Drapkin R
Cancer Res; 2019 Feb; 79(4):760-772. PubMed ID: 30563893
[TBL] [Abstract][Full Text] [Related]
11. High-grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease.
Zhai Y; Wu R; Kuick R; Sessine MS; Schulman S; Green M; Fearon ER; Cho KR
J Pathol; 2017 Sep; 243(1):16-25. PubMed ID: 28608929
[TBL] [Abstract][Full Text] [Related]
12. Mutant p53 expression in fallopian tube epithelium drives cell migration.
Quartuccio SM; Karthikeyan S; Eddie SL; Lantvit DD; Ó hAinmhire E; Modi DA; Wei JJ; Burdette JE
Int J Cancer; 2015 Oct; 137(7):1528-38. PubMed ID: 25810107
[TBL] [Abstract][Full Text] [Related]
13. PAX2-null secretory cell outgrowths in the oviduct and their relationship to pelvic serous cancer.
Quick CM; Ning G; Bijron J; Laury A; Wei TS; Chen EY; Vargas SO; Betensky RA; McKeon FD; Xian W; Crum CP
Mod Pathol; 2012 Mar; 25(3):449-55. PubMed ID: 22080059
[TBL] [Abstract][Full Text] [Related]
14. [Expansion of secretory cells in the fallopian tubal epithelium in the early stages of the pathogenesis of ovarian serous carcinomas].
Asaturova AV; Ezhova LS; Faizullina NM; Adamyan LV; Khabas GN; Sannikova MV
Arkh Patol; 2017; 79(3):10-18. PubMed ID: 28631711
[TBL] [Abstract][Full Text] [Related]
15. Activin A stimulates migration of the fallopian tube epithelium, an origin of high-grade serous ovarian cancer, through non-canonical signaling.
Dean M; Davis DA; Burdette JE
Cancer Lett; 2017 Apr; 391():114-124. PubMed ID: 28115208
[TBL] [Abstract][Full Text] [Related]
16. The Repertoire of Serous Ovarian Cancer Non-genetic Heterogeneity Revealed by Single-Cell Sequencing of Normal Fallopian Tube Epithelial Cells.
Hu Z; Artibani M; Alsaadi A; Wietek N; Morotti M; Shi T; Zhong Z; Santana Gonzalez L; El-Sahhar S; Carrami EM; Mallett G; Feng Y; Masuda K; Zheng Y; Chong K; Damato S; Dhar S; Campo L; Garruto Campanile R; Soleymani Majd H; Rai V; Maldonado-Perez D; Jones S; Cerundolo V; Sauka-Spengler T; Yau C; Ahmed AA
Cancer Cell; 2020 Feb; 37(2):226-242.e7. PubMed ID: 32049047
[TBL] [Abstract][Full Text] [Related]
17. Prolactin signaling drives tumorigenesis in human high grade serous ovarian cancer cells and in a spontaneous fallopian tube derived model.
Karthikeyan S; Russo A; Dean M; Lantvit DD; Endsley M; Burdette JE
Cancer Lett; 2018 Oct; 433():221-231. PubMed ID: 29981811
[TBL] [Abstract][Full Text] [Related]
18. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors].
Wen J; Shi JL; Shen DH; Chen YX; Song QJ
Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):433-7. PubMed ID: 22932451
[TBL] [Abstract][Full Text] [Related]
19. Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium.
Rodgers LH; Ó hAinmhire E; Young AN; Burdette JE
Oncotarget; 2016 May; 7(22):32785-95. PubMed ID: 27129161
[TBL] [Abstract][Full Text] [Related]
20. NF-κB-miR-155 axis activation mediates ovulation-induced oncogenic effects in fallopian tube epithelium.
Brand H; Barnabas GD; Sapoznik S; Bahar-Shany K; Pozniak Y; Yung Y; Hourvitz A; Geiger T; Jacob-Hirsch J; Levanon K
Carcinogenesis; 2020 Dec; 41(12):1703-1712. PubMed ID: 32614381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
